ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Reports On AACR Scientific Sessions

May 21, 1976

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005